Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-18-005806

Options or other derivatives

  • CEO acquired 220,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LEONARD JOHN M. · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-25 Grant or award : show line 1 in the form Stock Option (right to buy) +220,000 220,000 D
Loading xslF345X03/doc4.xml…